sulfabenzamide Report issue

Small molecule Approved FDA
ChEMBL Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Sulfabenzamide is an antibacterial/antimicrobial. Often used in conjunction with sulfathiazole and sulfacetamide (trade name - Sultrin) as a topical, intravaginal antibacterial preparation against Haemophilus (Gardnerella) vaginalis bacteria. The mode of action of SULTRIN is not completely known. Indirect effects, such as lowering the vaginal pH, may be equally important mechanisms.   NCATS

Chemistry

  • SMILES: NC1=CC=C(C=C1)S(=O)(=O)NC(=O)C2=CC=CC=C2
  • InChIKey: PBCZLFBEBARBBI-UHFFFAOYSA-N
  • Mol. Mass: 276.311
  • ALogP: 1.39
  • ChEMBL Molecule:
    sulfabenzamide  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Topical
  • Pro Drug: No

Combination drugs

( sulfacetamide (sultrin), sulfathiazole, sulfabenzamide )

Alternative names

benzamide, n-((4-aminophenyl)sulfonyl)- | sulfabenzamid | sulfabenzamide | sulfabenzamide (triple sulfa) | sulfabenzid | sulfabenzide | sulfabenzoylamide

Organizations (9)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (9)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (1)

Approved Indications (1)


 

Vaginitis (approved 1945)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue